Spark Therapeutics
	Developer of gene therapy products. The company develops gene therapy products to address debilitating diseases including retinal dystrophies.
	['', 'gene therapy', ' ', 'disease treatment', ' ', 'medical research', '']
REGENXBIO
	Operator of an adeno-associated virus gene therapy company. The company develops proprietary gene therapy tech to advance treatments for lysosomal storage disorders and ocular diseases, as well as other serious diseases.
	['', 'gene therapy', ' adeno-associated ', 'viral vector', ' ', 'clinical trail', '']
Xenon Pharmaceuticals
	Developer of medicines focused on rare diseases. The company\'s core enabling discovery platform is focused on studying rare human diseases with extreme traits, including diseases caused by mutations in ion channels, known as channelopathies.
	['', 'rare disease', ' channelopathy ', 'gene therapy', ' ', 'discovery platform', ' ', 'ion channel mutation', '']
Dimension Therapeutics
	Developer of gene therapies for rare diseases. The company develops novel treatment and focus on advancing its platform of gene therapy programs in rare diseases through clinical development, starting with lead programs in hemophilia and building out a world-class product engine for adeno-associated virus (AAV) therapeutics.
	['', 'novel treatment', ' ', 'gene therapy', ' ', 'clinical development', '']
